• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Complex Regional Pain Syndrome (CRPS) – A Market Briefing

$795.00 – $1,990.00

Clear
SKU: KLI1052649 Category: Pharmaceuticals Market Research Pages: 58
  • Description
  • Table of Contents
  • Latest reports

Description

Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection.

On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy (RSD). This pain is often burning in nature and is usually caused by an injury involving variable sensory, motor, autonomic and trophic changes. There can be many causes for CRPS. For the most part, it is the result of an accidental trauma. This trauma can be minor, as with a cut, sprain or fracture or more severe, as with a major crush injury or post-surgical procedure.

Because the sympathetic nervous system affects so many different systems of the body, RSD-CRPS is a complex and little understood disorder, and provides a unique and underserved market opportunity for pain management products.

This briefing analyzes the potential world market for treatments for CRPS-RSD. The report generally reviews the nature and direction of research, as well as future markets. This briefing also profiles several companies involved in developing such products in the field, as well as treatments for neuropathic pain that could eventually be applied to treat CRPS. Such companies include AlgoRx Pharmaceuticals, Cell Targeting Technologies and NeurogesX.

Market forecasts, made through 2009 for four major global regions, are based on an examination of current market conditions and on investigations into the development of new products by key companies. This information is also weighted with the projected timing and the potential for receiving regulatory approvals to market products. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians, researchers and public health officials.

Table of Contents

Chapter One: Executive Summary

  • Overview of Neuropathic Pain
  • Complex Regional Pain Syndrome
  • A Market Niche
  • Potential Treatments
  • Market Summary
  • Scope and Methodology

 

Chapter Two: Introduction

  • Pain
    • A Complex Process
    • Pathways
    • Types of Pain
    • Describing Pain
  • Problems with Current Management
  • Complex Regional Pain Syndrome
    • Underlying Pain Condition
    • Four Stages
    • Current Treatments
    • Extent and Incidence
  • Promising Research
    • Common Anesthetic
    • Simple Injection
    • Hyperbaric Oxygen Therapy
    • Antileptic Drugs

Chapter Three: Markets

  • Neuropathic Pain
    • Drug Categories
    • Market Forecast
    • Chronic Regional Pain Syndrome
      • Current Drug Management
      • Market Forecasts

Chapter Four: Corporate Profiles

  • AlgoRx Pharmaceuticals Inc.
  • Amgen Inc.
  • Bayer AG
  • Cell Targeting Technologies
  • CeNeS Pharmaceuticals plc
  • Forest Laboratories Inc.
  • GlaxoSmithKline plc
  • King Pharmaceuticals Inc.
  • Eli Lilly & Co.
  • NeurogesX Inc.
  • Pfizer Inc.

list of exhibits

Chapter One: Executive Summary

  • Exhibit 1: Extent and Impact of Chronic Regional Pain Syndrome
  • Exhibit 2: World Prevalence of CRPS and Neuropathic Pain 2005
  • Exhibit 3: Potential World Market for CRPS 2005-2009

Chapter Two: Introduction

  • Exhibit 4: Most Commonly Used Pain Quality Descriptors

Chapter Three: Markets

  • Exhibit 5: World Market for Neuropathic Pain Therapy 2005-2009
  • Exhibit 6: US Market for Neuropathic Pain Therapy 2005-2009
  • Exhibit 7: Potential World Market for CRPS 2005-2009
  • Exhibit 8: Potential North American Market for CRPS 2005-2009
  • Exhibit 9: Potential European Market for CRPS 2005-2009
  • Exhibit 10: Potential Rest of World Market for CRPS 2005-2009

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    $2,500.00 – $5,000.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00
  • Placeholder image

    Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”

    $1,121.00 – $1,717.00
  • Placeholder image

    Emerging Cancer Vaccine Market, The

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Wound Care Markets, 2nd Edition, Vol I – Skin UlcersWound Care Markets, 2nd Edition, Vol II – Burns
Scroll to top